How to manage uncomplicated acne at the first visit?
Managing uncomplicated acne vulgaris at the first visit requires a structured approach that balances accurate assessment, appropriate treatment selection, and thorough patient education. Acne affects most adolescents and can persist into adulthood, making it one of the most common presentations in dermatology and primary care. The following protocol aligns with NICE guidelines for managing acne in patients from age 12 onward.
Assessing the Patient
Begin by evaluating the severity and distribution of lesions. Grade acne as mild, moderate, or severe based on the presence of comedones, papules, pustules, and nodules. Assess the patient for psychological distress, as acne can significantly impact self-esteem and quality of life.
Explore any previous treatments the patient has tried, including over-the-counter products. Document the duration of the condition and whether lesions are flaring or persistent. For patients with childbearing potential, discuss the risk of pregnancy because topical retinoids and oral tetracyclines are contraindicated during pregnancy and when planning to conceive.
Patient Education
Patient education is foundational to successful acne management. Cover the following points during the first visit:
- Acne is not caused by poor hygiene. Over-cleaning can worsen irritation and dryness.
- Effective treatment takes time. Positive results typically require 6 to 8 weeks, and a full course lasts 12 weeks.
- Topical treatments often cause initial skin irritation. Starting with alternate-day application or short-contact use (washing off after an hour) can reduce this.
- Patients should avoid oil-based, comedogenic skincare products and makeup. If makeup is used, it must be removed at the end of the day.
- Persistent picking or scratching of lesions increases scarring risk.
- No specific diet has proven efficacy for treating acne, although high glycaemic index diets may exacerbate it. Advise a healthy balanced diet.
Direct patients to reliable resources such as the NHS Acne page or the British Association of Dermatologists for further information.
Step-by-Step Treatment Protocol
Step 1: Select Treatment Based on Severity
For mild to moderate acne, offer a 12-week course of one of the following first-line options applied once daily in the evening:
- A fixed combination of topical adapalene (0.1% or 0.3%) with benzoyl peroxide (2.5%)
- A fixed combination of topical tretinoin (0.025%) with clindamycin (1%)
- A fixed combination of topical benzoyl peroxide (3% or 5%) with clindamycin (1%)
If these options are contraindicated or the patient wishes to avoid retinoids or antibiotics, consider topical benzoyl peroxide as monotherapy. Choose the formulation based on skin type: creams or lotions for dry or sensitive skin, gels for oily skin.
Step 2: Escalate for Moderate to Severe Acne
For moderate to severe acne, offer a 12-week course combining topical and systemic treatment:
- A fixed combination of adapalene with benzoyl peroxide applied once daily in the evening, plus oral lymecycline 408 mg or oral doxycycline 100 mg once daily
- Topical azelaic acid (15% or 20%) applied twice daily, plus oral lymecycline or doxycycline
- The same fixed-combination topicals listed above for mild to moderate acne, but used with oral antibiotics rather than alone
If tetracyclines are contraindicated or not tolerated, consider trimethoprim or an oral macrolide such as erythromycin as alternatives.
Step 3: Avoid Ineffective Combinations
Do not prescribe any of the following:
- Topical antibiotic monotherapy
- Oral antibiotic monotherapy
- Combined topical and oral antibiotics together
These approaches carry an unacceptable risk of antibiotic resistance without sufficient clinical benefit.
Step 4: Consider Hormonal Options for Women
For women with moderate to severe acne, combined oral contraceptives can be considered as an alternative to systemic antibiotics when used alongside topical agents. Avoid progesterone-only contraceptives or progestin implants with androgenic activity, as these may worsen acne. Co-cyprindiol may be considered for treatment-resistant cases after careful risk discussion, but should be discontinued 3 months after acne is controlled.
Step 5: Minimize Skin Irritation
Advise patients to use a non-alkaline synthetic detergent cleanser twice daily on acne-prone skin. For topical treatments, start with reduced frequency (once or twice weekly) and gradually increase to daily as tolerated. If irritation occurs, reduce concentration or application frequency temporarily.
Step 6: Arrange Follow-Up
Schedule a follow-up appointment at 12 weeks to assess treatment response. Patients who relapse quickly after stopping treatment may benefit from extending antibiotic courses to 6 months, but courses should not exceed this duration due to resistance risk.
Red Flags
- Severe nodulocystic acne requiring urgent dermatology referral
- Significant acne-related scarring that is severe and persists more than a year after clearance
- Signs of secondary bacterial infection (widespread impetiginization, cellulitis)
- Severe psychological distress requiring mental health referral
- Acne associated with signs of hyperandrogenism in women (hirsutism, menstrual irregularities, alopecia), which may indicate an underlying endocrine disorder
- Acne that is treatment-resistant after appropriate courses of oral antibiotics combined with topical therapy
Common Questions
Why can't I prescribe an oral antibiotic alone?
Oral antibiotic monotherapy is not recommended because of the risk of selecting antibiotic-resistant Cutibacterium acnes bacteria. Combining with benzoyl peroxide or a topical retinoid targets multiple pathophysiological pathways and reduces resistance risk.
How long should treatment continue before assessing efficacy?
A minimum of 6 to 8 weeks is needed before positive effects become noticeable. A full course is 12 weeks. Assessing treatment response before this point may lead to premature discontinuation of an effective regimen.
What if the patient wants to stop treatment due to skin irritation?
Skin irritation is common, especially at the start of topical retinoid or benzoyl peroxide therapy. Advise starting with alternate-day or short-contact application and gradually building tolerance. Switching to a cream formulation from a gel can also reduce irritation. If irritation persists, consider azelaic acid as a less irritating alternative.
Protocol Summary
- Assess severity, distribution, and psychological impact at the first visit
- Screen for pregnancy risk in patients with childbearing potential before prescribing retinoids or tetracyclines
- Educate the patient on gentle cleansing, avoiding comedogenic products, and realistic treatment timelines
- For mild to moderate acne, prescribe a 12-week course of fixed-combination topical therapy applied once daily in the evening
- For moderate to severe acne, combine topical treatment with an oral tetracycline (doxycycline or lymecycline)
- Avoid all forms of antibiotic monotherapy and combined oral plus topical antibiotic use
- Consider combined oral contraceptives for women with moderate to severe acne
- Arrange follow-up at 12 weeks to assess response and adjust treatment as needed
How Rovetia Helps
Rovetia helps dermatology clinicians maintain a structured patient timeline across visits. Upload clinical photos, document treatment plans, and use AI-assisted note generation to capture the initial acne assessment details. Track treatment progress over time and quickly review each patient's history during follow-up appointments, ensuring no details about previous regimens or medication responses are lost.
Sources
- Acne vulgaris: Scenario: Management of acne vulgaris in primary care | CKS | NICE
- Recommendations | Acne vulgaris: management | Guidance | NICE
- Acne vulgaris: How should I assess a person with suspected acne vulgaris? | CKS | NICE